Development of 17O NMR approach for fast imaging of cerebral metabolic rate of oxygen in rat brain at high field

A comprehensive technique was developed for using three-dimensional 17O magnetic resonance spectroscopic imaging at 9.4T for rapidly imaging the cerebral metabolic rate of oxygen consumption (CMRO2) in the rat brain during a two-min inhalation of 17O2. The CMRO2 value (2.19 ± 0.14 μmol/g/min, n = 7) was determined in the rat anesthetized with α-chloralose by independent and concurrent 17O NMR measurements of cerebral H217O content, arterial input function, and cerebral perfusion. CMRO2 values obtained were consistent with the literature results for similar conditions. Our results reveal that, because of its superior sensitivity at ultra-high fields, the 17O magnetic resonance spectroscopic imaging approach is capable of detecting small dynamic changes of metabolic H217O during a short inhalation of 17O2 gas, and ultimately, for imaging CMRO2 in the small rat brain. This study provides a crucial step toward the goal of developing a robust and noninvasive 17O NMR approach for imaging CMRO2 in animal and human brains that can be used for studying the central role of oxidative metabolism in brain function under normal and diseased conditions, as well as for understanding the mechanisms underlying functional MRI.

[1]  M Dujovny,et al.  Determination of regional cerebral oxygen consumption in the human: 17O natural abundance cerebral magnetic resonance imaging and spectroscopy in a whole body system. , 1993, Neurological research.

[2]  A. Howseman,et al.  1H-[13C] NMR measurements of [4-13C]glutamate turnover in human brain. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[3]  M J Welch,et al.  The measure in vivo of regional cerebral oxygen utilization by means of oxyhemoglobin labeled with radioactive oxygen-15. , 1970, The Journal of clinical investigation.

[4]  M J Welch,et al.  Positron Emission Tomographic Measurement of Cerebral Blood Flow and Permeability—Surface Area Product of Water Using [15O]Water and [11C]Butanol , 1987, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[5]  S. Kety,et al.  THE NITROUS OXIDE METHOD FOR THE QUANTITATIVE DETERMINATION OF CEREBRAL BLOOD FLOW IN MAN: THEORY, PROCEDURE AND NORMAL VALUES. , 1948, The Journal of clinical investigation.

[6]  C J Thompson,et al.  Oxygen Consumption of the Living Human Brain Measured after a Single Inhalation of Positron Emitting Oxygen , 1992, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[7]  L. Sokoloff,et al.  Effects of anesthesia on functional activation of cerebral blood flow and metabolism , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[8]  M. Mintun,et al.  Nonoxidative glucose consumption during focal physiologic neural activity. , 1988, Science.

[9]  K Ugurbil,et al.  17O relaxation time and NMR sensitivity of cerebral water and their field dependence , 2001, Magnetic resonance in medicine.

[10]  L. Packer,et al.  Water and Ions in Biological Systems , 1985, Springer US.

[11]  Richard S. J. Frackowiak,et al.  The cerebral metabolism of glucose and oxygen measured with positron tomography in patients with mitochondrial diseases. , 1988, Brain : a journal of neurology.

[12]  J. Pekar,et al.  In Vivo measurement of cerebral oxygen consumption and blood flow using 17O magnetic resonance imaging , 1991, Magnetic resonance in medicine.

[13]  M. Raichle,et al.  What is the Correct Value for the Brain-Blood Partition Coefficient for Water? , 1985, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[14]  G F Mason,et al.  Dependence of Oxygen Delivery on Blood Flow in Rat Brain: A 7 Tesla Nuclear Magnetic Resonance Study , 2000, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[15]  M. Mintun,et al.  Brain oxygen utilization measured with O-15 radiotracers and positron emission tomography. , 1984, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[16]  A. Hopkins,et al.  Oxygen‐17 compounds as potential NMR T2 contrast agents: Enrichment effects of H217O on protein solutions and living tissues , 1987, Magnetic resonance in medicine.

[17]  J A Frank,et al.  Simultaneous Measurement of Cerebral Oxygen Consumption and Blood Flow Using 17O and 19F Magnetic Resonance Imaging , 1995, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[18]  H. Möller,et al.  A selective defect of cytochrome c oxidase is present in brain of Alzheimer disease patients , 2000, Neurobiology of Aging.

[19]  M. Kawakami,et al.  Vidarabine therapy for virus-associated cystitis after allogeneic bone marrow transplantation , 1997, Bone Marrow Transplantation.

[20]  B. Siesjö,et al.  Brain energy metabolism , 1978 .

[21]  B. Rosen,et al.  Proton NMR imaging of cerebral blood flow using H2 17O , 1991, Magnetic resonance in medicine.

[22]  Marcia Barinaga,et al.  Neuroscience: What Makes Brain Neurons Run? , 1997, Science.

[23]  F. Hyder,et al.  Increased tricarboxylic acid cycle flux in rat brain during forepaw stimulation detected with 1H[13C]NMR. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[24]  A A Lammertsma,et al.  CMRO2 and CBF by the oxygen-15 inhalation technique. Results in normal volunteers and cerebrovascular patients. , 1981, European neurology.

[25]  G. Navon,et al.  A new method for proton detection of H217O with potential applications for functional MRI , 1994, Magnetic resonance in medicine.

[26]  Donald S. Williams,et al.  Tissue specific perfusion imaging using arterial spin labeling , 1994, NMR in biomedicine.

[27]  H. Möller,et al.  Evidence for a mitochondrial oxidative phosphorylation defect in brains from patients with schizophrenia , 2001, Schizophrenia Research.

[28]  Piero Antuono,et al.  Cytochrome oxidase in Alzheimer's disease: Biochemical, histochemical, and immunohistochemical analyses of the visual and other systems , 1997, Vision Research.

[29]  S. Laughlin,et al.  An Energy Budget for Signaling in the Grey Matter of the Brain , 2001, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[30]  C T Moonen,et al.  In vivo 17O NMR study of rat brain during 17O2 inhalation , 1992, Magnetic resonance in medicine.

[31]  K. Uğurbil,et al.  Imaging of H217O distribution in the brain of a live rat by using proton-detected 17O MRI. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[32]  M. Beal,et al.  Does impairment of energy metabolism result in excitotoxic neuronal death in neurodegenerative illnesses? , 1992, Annals of neurology.

[33]  K. Uğurbil,et al.  Study of tricarboxylic acid cycle flux changes in human visual cortex during hemifield visual stimulation using 1H‐{13C} MRS and fMRI , 2001, Magnetic resonance in medicine.

[34]  N. Harel,et al.  Blood capillary distribution correlates with hemodynamic-based functional imaging in cerebral cortex. , 2002, Cerebral cortex.

[35]  K. Ishimori,et al.  Cerebral oxygen utilization analyzed by the use of oxygen-17 and its nuclear magnetic resonance. , 1990, Biochemical and biophysical research communications.

[36]  R. Shulman,et al.  NMR Determination of the TCA Cycle Rate and α-Ketoglutarate/Glutamate Exchange Rate in Rat Brain , 1992 .